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Abstract. The aim of this survey 
research was to study the perceptions 
of public and private sector physicians 
toward Direct to Consumer Pharmaceutical Advertisements 
(DTCPA) with the help of triangulated study approach. Using 
cluster sampling technique, the primary data was collected via 
adapted questionnaire and, 389 completely filled questionnaires 
were compiled out of 400 questionnaires distributed. Data analysis 
was conducted in SPSS by using descriptive statistics and t-test. 
Results revealed that private sector physicians are more inclined 
towards DTCPA; they believe that DTCPA can help to improve 
physician patient relationship, diagnosis and treatment plans. 
However, self-medication and undesirable interventions from 
patients can increase the healthcare hazards and cost. Moreover, 
the public sector physician’s tendency towards DTCPA is 
comparatively less than private sector, even though majority of 
public sectors physicians have also favored the stance to achieve 
better healthcare outcomes. 
Keywords:  Physician perception, patient demand, physician patient 
relationship, physician prescribing behavior 
Introduction 
The marketing of medicines from the organization point of view is equally 
crucial as the development and production of the product is important. 
Marketing in pharmaceutical is being run through two broad concepts i.e. 
conventional and contemporary practices. In practice, conventional marketing 
refers to physician focus promotional campaigns that influence physician 
prescribing behavior rather than patient as the consumer of medicine. On the 
contrary, contemporary marketing practices are similar to Fast Moving 
Consumer Goods (FMCG) firms’ practices, in which consumer of the products 
are the primary target audience (Rao, 2012). Conventional pharmaceutical 
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marketers adapt different strategies and use multiple instruments in the context 
of marketing mix to influence the physician prescribing decision towards their 
interest of products (Shah, Khan, Ayub, & Anwar, 2017). While, contemporary 
or DTCPA is an approach in which marketer directly target the patients and at 
the same time tactfully tries to influence the physician and other stakeholders 
(e.g. patient family, social community, business partners, social blogs etc.), 
through high resonance of brand messages (Dey, Rautray, & Soni, 2019). 
DTCPA is relatively new concept of pharmaceutical advertisements for 
millennial generation (Generation–Y) as compared to conventional marketing 
practices (Rao, 2012), though the concept was started in 1980’s in US market. 
Currently it’s allowed only in USA and Newzealand (Siraj & Curley, 2018), in 
lined with Food Drug Administration’s (FDA) rules for drug advertisements; 
which can be categorized into three types of advertisements i.e. the product 
claim ads, brand reminder ads and help-seeking ads  (Food & Drug 
Administration, 2015). However, it has now been accelerated with 
technological advancement and digitalization of industries (Narula, 2017). 
Although digitalization is yet to be transformed in pharmaceutical from 
conventional marketing practices as compared to FMCG’s and banking fields 
(Ivan’s, 2006), especially, in local context of Pakistan. 
In Pakistan, DTCPA is allowed for help-seeking ads and only for over the 
counter products, but not for prescription products (Jacob, 2018; Siddiqi & 
Shah, 2017b). The healthcare system in Pakistan mainly comprise of public and 
private sectors. Private sector has effectively bridged the gap of healthcare 
facilities due to increase in population and limited healthcare budget allocation 
from government side (World Health Organization, 2017). This situation on 
one side promote healthcare, whilst on other hand, it promote commercialism 
in health sector of Pakistan, patients are considered as a source of income and 
being exploited even by the noble professionals (Masood, Wang, Daud, 
Aljohani, & Dawood, 2018). 
In reality, patient demand is least considered by the physicians, patient is 
often neglected because of low health literacy and lack of knowledge about the 
subject (Grunloh, Myreteg, Cajander, & Rexhepi, 2018). Moreover, physician 
induced demands are the main cursers to shift the curve of patient demands 
towards physician demands (Mohammadshahi et al., 2019). Despite, patient 
being the expert of his surroundings better understand their socio economic 
status and preferences of life than physician, they are static entities during 
health care decisions. Considering, patients can develop skills and knowledge 
to read and understand health records through e-portals or DTCPA, they will be 
encouraged asking more relevant and right questions to participate in their 
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healthcare decisions, which will promote impartiality between physician 
patient relationship (Cutler, Skinner, Stern, & Wennberg, 2019). 
Physician believes and organizational factors are the dominant factors that 
drive the physician decision during physician patient interaction 
(Mohammadshahi et al., 2019; Zaman, Asim, Shah, & Ahmed, 2018), 
especially, in the context of local setup of Pakistan such as public and private 
sectors, where; “patients are less participatory and being neglected by 
physicians while deciding about their healthcare plans” (World Health 
Organisation, 2017). 
What are the perception differences about DTCPA among public and 
private sectors physicians in Pakistan is an important point to ponder upon and 
in this regard, the study at hand intends: 
1. To assess the physician perception about usefulness of direct to consumer 
pharmaceutical advertisement to achieve balance between physician 
patient relationships. 
2. To measure the tendencies of private and public sectors physician toward 
DTCPA in the context of Pakistan.  
3. To provide condensed basis to understand conventional and contemporary 
pharmaceutical marketing practices. 
Physician’s perception about DTCPA has been thoroughly studied in 
respect to private and public sectors in the local context of Pakistan as 
suggested by Zaman et al. (2018) and Shah et al. (2017).  
This study intends to enhance the existing knowledge of contemporary 
pharmaceutical advertisement practices impact on physician prescribing 
behavior, which is relatively a new concept, with particular reference to the 
academic and managerial implications in Pakistan. It set avenues for future 
research to explore the contemporary pharmaceutical marketing practices, 
particularly, in the context of Pakistan.  
Literature Review 
The history of drug dispensing is as ancient as human origin; this can be traced 
back through the study of ethno regional divisions of human beings e.g. 
Egyptian, Chinese, European and African etc. (Saah, 2005). However, the drug 
as a regulated commodity is linked back to 1820, when for the first time United 
State Pharmacopeia (USP) i.e. a compendium of standard drugs was formulated 
by eleven physicians at Washington DC. Prior to the American Medical 
Association (AMA), which was established in 1905, patients or consumers 
were not restricted to obtain any compounds from doctors or neither pharmacist 
nor the sellers were regulated. There were only two classes of drugs as “ethical 
 
Shahzad et al. 
86 Vol. 7, Issue 1 ISSN 2414-2336 (Print), ISSN 2523-2525 (Online) 
 
group” listed in USP and the other “patent or proprietary group”. These drugs 
were made of hidden ingredients; generally consist of mixture of substances as 
oil or tonic syrups under the trademark names. These drugs were directly 
advertised to consumers through posters, newspapers and product packages, the 
contents of their ads were an oil compound claimed such as “to get rid of all 
types of body pain” or “tonic syrup for stronger back bone”. In contrast, the 
ethical group drugs were not advertised to consumers, because of the organized 
efforts of USP (Dodgson, 2006; Donohue, 2006).  
In 1906 the Food and Drug Administration (FDA) originated as law 
enforcing organization, since it was founded in 1862 as scientific institution to 
monitor clinical trials but the new role of FDA have had little impact on the 
patent group industry (Dodgson, 2006). In 1938 FDA amended the Food, Drug 
and Cosmetic Act (FDCA) with expanded regulations for manufacturer to label 
the drug name, ingredients and FDA user safety approval prior the drug could 
be marketed. This was first time when Over the Counter (OTC) and 
prescription drugs concept was exempted from conditional medicines 
marketing. However, proper definition of OTC and prescription drugs was 
given in 1951 (Donohue, Cevasco, & Rosenthal, 2007). 
Conventional pharmaceutical advertisements 
The American Medical Association (AMA) being the opponent of the direct to 
consumer advertisements, regarded the self-medication as threat to medical 
profession; they created an incentive plan for pharmaceutical companies to 
advertise medicines only to physicians on ethical grounds (Donohue, 2006). 
Since 1938, pharmaceutical companies shifted their focus of advertisements 
from consumer to doctors, this era was considered as boom of pharmaceutical 
revenues, many conventional pharmaceutical marketing models were applied to 
understand the physician prescribing decisions. A medical representative 
concept as “detail men” was introduced in 1958. The “detail men” was a 
company representative; they were used to visit the physicians to introduce 
companies’ medicines and builds relationship with physicians. Physicians had 
been shown dependence on “detail men”, for drug information, promotional 
materials and for different promotional activities including academic sessions; 
in return physicians prescribed the product of medical representative to 
patients. 
According to Savedoff (2004) the asymmetry of information exists between 
physician and patient; he argued that equilibrium in health cannot be achieved, 
due to tradeoff between health optimization and cost associated with third party 
decision making power (i.e. physician). He further says that a fundamental gap 
exist between physician and patient in terms of context of the parties. He 
applied agency theory concept in physician patient relationship (Donohue, 
 
Sarhad Journal of Management Sciences (SJMS) 
 
87 Vol. 7, Issue 1  ISSN 2414-2336 (Print), ISSN 2523-2525 (Online) 
 
2006), in which physician as an agent was responsible for all health related 
decisions for his principal (patient) due to physician distinct knowledge and 
skills (Savedoff, 2004).  Physician with distinct knowledge in conventional 
practices, least considered patient’s demands, while prescribing products to 
patients due to fundamental distinction. Patients being the primary consumers 
of the medicines considered as static entity for his health care decisions. The 
entire decision making power is (was) with physician. Therefore in 
conventional practices, the target audience for advertising campaigns are 
always physicians (Ahmed et al., 2014). Physician will remain the primary 
customer for pharmaceutical companies and to influence the doctor’s 
prescribing behavior, pharmaceutical companies use different tools as 
marketing mix to influence the prescribing decision (Shahzad & Wahab, 2016). 
Although, there were some American scholars who stressed that doctors should 
not take solely the decisions on patient behalf. Therefore; different physician 
patient relationship models have been developed as solution to balance between 
physician authority and patient autonomy, especially, when consumer right 
movement was extended to patient right movement in 1970 after a report 
published on biomedical research abuse of humans (Savedoff, 2004). 
Contemporary pharmaceutical advertisements 
Since, consumerism rights movement was thought provoking point for 
marketers to rethink for an alternative option to physician focus strategy for the 
promotion of medicines. The tradition was broken by Brooks enterprise in 1980 
for it product “Rufen” a painkiller and followed by Merck which had begun 
direct to consumer advertisement for “Pneumovax”, a vaccine formulation for 
pneumonia. Meanwhile, no explicit regulation was available to monitor 
DTCPA until 1983, when FDA voiced the matter and stopped the companies 
from DTCPA by de facto of 1969 act. However, in 1985 proper guidelines 
were formulated after public debate on pros and cons of DTCPA, legislation 
for DTCPA in USA was passed followed by revision in 1997. 
Currently pharmaceutical companies are being regulated by FDA under 
2015 drugs advertisements criteria, which state three categories of ads i.e. help 
seeking ads, brand reminder ads and product claim ads (Food & Drug 
Administration, 2015). Direct to consumer pharmaceutical advertisements is 
similar to Fast Moving Consumer Goods (FMCG) advertising model, in which 
marketer directly advertise the medicines to the consumer (patients), through 
brand story messages to increase the noise level for brand awareness in order to 
generate revenues for organization (Pharma, 2017). DTC advertisings are 
drafted in such way that can influence both the patients and physicians as well 
their other stakeholders (i.e. family, social community, business partners, social 
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blogs etc) (Santana et al., 2019). DTC ad content help the undiagnosed patients, 
who see the ad content that reflects story or symptoms from audience are being 
suffered, they gets stimulation and start discussing about disease with himself, 
doctors, family, and friends or start searching at internet, about disease 
prevention and available treatment options (Epstein, Fiscella, Lesser, & Stange, 
2010). 
However there is debate on merits and demerits of patient’s centric or DTC 
pharmaceutical advertisements (Arney, Street Jr, & Naik, 2013). The prevailing 
debate exist due to the types of pharmaceutical products and risks associated to 
humans (Watson, 2015) including role of regulatory authorities (Food and 
Drug Adminstration, 2015). According to Murray, Lo, Pollack, Donelan, and 
Lee (2004), DTCPA can play a major role in health behavior, health service 
utilization, and relationship building in order to encourage people of low 
socioeconomic status for the benefits of preventive care. In views of Hampl, 
Bramlett-Solomon, and Wharton (2006), DTCPA can help to increase the 
productivity of advertising by almost US$ 4.2 additional revenues generation 
from every US$- 1 expenditures, moreover  top 25 pharmaceutical companies 
around the globe have increased their social media marketing budgets since 
2012, approximately US$ 9.7 billion has been spent in 2015 for DTCPA (Julie, 
2016). According to Siddiqi and Shah (2017a) physician also encouraged 
DTCPA, which is supplementary for health care system of the country. 
Besides, Preechavuthinant, Willis, and Coustasse (2018) mentioned in their 
research paper that patients had shown higher satisfaction associated with 
DTCPA prescribed drug. From patient’s perspective, it is further found that 
patient centric advertisement enhanced the patient’s confidence to discuss 
about his disease symptoms and treatment options with physicians. Patient gets 
help early to register themselves timely to improve the quality of life 
(Defibaugh, 2019; Epstein & Street, 2011). Moreover, it can also help to 
improve the quality of life and patient’s well-being, however self-medication 
adherence need to be mitigated by providing quality information through 
digital media (Or & Karsh, 2009). 
In view of Pandey, Jha, and Saha (2019) DTCA can manipulate the 
physician patient relationship and can lead to dissatisfaction of patients. Ortiz 
and Rosenthal (2019) argued that DTCPA will bring the trust in physician on 
stake if the trend continue to be unchecked by authorities. Ghani, Waqar, 
Jambulingam, and Sharma (2019) suggested that it can be more beneficial for 
branded products than generics particularly for companies with huge marketing 
expenditures. Siraj and Curley (2018) highlighted the importance of burden of 
responsibility in case adverse event occurred due to misleading information; 
whether patient misunderstood or the quality of message was weak. 
Furthermore, being the strongest opponent of DTCA; Stange (2007) 
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recommended to ban the DTCA due to risks associated with human lives. 
However, the solution is to improve the quality of information, the content of 
ad should be more meaningful for consumers rather mislead the patients 
(Adams, 2016). Some other authors’ findings on DTCPA in critical review 
perspective have been enlisted in table 1. 
Table 1.  Chronological literature review on DTCPA 
Author’s Methodology Findings 
Rentmeester 
(2020) 
A qualitative analysis 
of DTCPA in 
historical and 
rationality perspective  
The contemporary term of patient 
autonomy is being exploited by 
pharmaceutical companies through 
irrational advertisement contents. 
Pieriegud (2019) 
A case study of 
Poland pharmaceutical 
market conversion of 
pharmacies to digital 
market.   
The increasing trend for digitalization 
in Poland pharmaceutical market has 
boosted OTC product sales due to e- 




on DTCPA from TV 
broadcasting contents. 
Provoking statements to patients 
encourage them to talk with doctors 
about symptoms and drug ads as 




analysis on DTCPA in 
context to USA 
market. 
DTCPA yet to be increased in coming 
times. However, trust in HCP may be 
at stake, if products continue to be 
promoted unchecked. 





approach to assess the 
effects of DTCPA on 
generic advertising 
companies’ revenues. 
DTCPA is favorable for both branded 
and generic base companies; 
However, generic products are less 
advertised on internet or DTCPA. 
Zaman et al. 
(2018) 
Cross section survey 




Physician takes DTCA and e-detailing 
as positive initiative for neutral-
ceuticals, however, physician needs to 
be more prepared to deal with 
informed patient for his higher 
satisfaction.  
Preechavuthinant 
et al. (2018) 
 
A systematic literature 
review on DTCPA 




DTCPA has influence over 
physician’s patient relationship and 
patient satisfaction. It has also 
increased the revenues for 
pharmaceutical companies. 
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In practice physician perceived patients as incompetent participant, while 
interacting for health related matters, due to lack of health literacy of the 
patient often neglected them during decision making process (Grunloh et al., 
2018). Sole decisions are made by Physician, which are being influenced by 
many factors such as physician contextual and organizational factors, 
promotional activities, peer and pharmacy influence including physician 
personal factors also play major role (Murshid, Mohaidin, & Zayed, 2019). In 
this scenario, where physicians have some pre-assumptions about patient 
aligned with the theory of planned behavior, and patients come with 
stimulation of DTCPA in view of stimulus response and mass communication 
theory of persuasion. How physicians will respond to this situation being a 
health agent. What are the perception differences of physicians based on their 
organizational differences such as public and private sectors? Hence, following 




Cross sectional survey 
in Pakistani context, 
assessed the 
knowledge, attitude 
and practices of 
medical ethics for 
patient care. 
There were significant difference of 
knowledge, attitude and practices 
among HCP; consultants were more 
aware particularly female staff. 
However, junior HCP needs to be 




Survey research on 
brand marketing 
strategies by small 
pharmaceutical brands 
in India. 
The small brands declined in sales 
due to inappropriate marketing 
strategies; people perceived low 
quality and price factor to avoid 
products.  
Siraj and Curley 
(2018) 
A systematic literature 
review of USA and 
New Zealand 
pharmaceutical market 
trend on DTCPA 
through 7 search 
engines.   
It has revealed that pharmaceutical 
companies using different techniques 
for advertising directly to consumer 
very successful. However, there is 
sizeable misleading information for 
patients, which needs to be review by 
marketers and regulatory bodies.  
Jiang (2018) 
A comparative trial on 
patient attitude 
towards HCP versus 
internet consultation. 
Consumer more trusts the prescription 






A case study of Indian 
pharmaceutical market 
in context to digital 
era. 
Indian pharmaceutical market is 
transforming to digitalization and can 
be more benefited via strategically 
transformation of pharmaceutical 
industry to e-content of advertising. 
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H1:  There are significant perception differences about DTCPA among 
public and private sectors physicians in Pakistan? 
Methodology 
It was a comparative survey with triangulated philosophy of research, to 
validate the quantitative results. Primary data was collected through a 
questionnaire, which was adapted from Murray et al. (2004). Using cluster 
random sampling, 389 completely filled questionnaires were compiled out of 
400 distributed. Data was analyzed through SPSS by using descriptive and 
independent t statistics. Moreover, for confirmative interviews a proportionate 
of study population was contacted to meet the minimum requirement of sample 
size for social sciences in lined with Creswell (2014) recommendation, 
especially, those had given consent to contact them back. 
Results 
It can be seen in table 2 that out of 389 compiled questionnaires almost 51% 
(n=197) respondents were from public sector and 49% (n=192) from private 
sector. In which approximately half of the study population were male 
respondents and rest were female. Moreover, the specialty of respondents were 
comparable in public sector i.e. physician and surgeon. However, in private 
sector physicians were in majority (62%) than surgeons respondents (38%), 
this data distribution was subjected to ground realities. Similarly, study 
population were widely experience in their field of work as mentioned in row 
for numbers of years of experience. 














The summary of following table 3 has been transformed from 5 point Likert 
scale into favored and un-favored classes for reader’s convenience and 
Items Public (n=197) Private (n=192) 
Gender 
 Male 53% 48% 
 Female 47% 52% 
Specialty 
 Physician  46% 62% 
 Surgeon 54% 38% 
Years of experience 
 0 – 4. 21% 27% 
 5 – 9. 55% 44% 
 10 – 14. 15% 23% 
 ≥15. 09% 06% 
 
Shahzad et al. 
92 Vol. 7, Issue 1 ISSN 2414-2336 (Print), ISSN 2523-2525 (Online) 
 
presented in Figure 1. Moreover, question number 1 to 6 has respectively been 
mentioned in following paragraphs that gives meaningful interpretations. 










Public Sector 0.50% 26.90% 0.50% 68.00% 4.10% 
Private Sector 1.0% 14.60% 2.10% 70.80% 11.50% 
2. 
Public Sector 0.50% 25.90% 1.00% 72.10% 0.50% 
Private Sector 0.50% 14.60% 0.50% 82.80% 1.60% 
3. 
Public Sector 0.50% 26.90% 0.0% 66.50% 6.10% 
Private Sector 0.50% 15.10% 0.0% 75.00% 9.40% 
4. 
Public Sector 0.0% 24.90% 0.50% 74.60% 0.0% 
Private Sector 0.0% 15.60% 0.50% 82.30% 1.60% 
5. 
Public Sector 0.0% 0.0% 1.00% 31.0% 68.00% 
Private Sector 0.0% 1.60% 0.50% 28.10% 69.80% 
6. 
Public Sector 0.50% 25.90% 0.50% 73.10% 0.50% 
Private Sector 0.50% 12.50% 0.00% 85.40% 1.60% 
The summary of individual responses on question 1 (can) encourage 
patients to attend physician for preventive care/treatment?) revealed that 
majority (82%) of study population in private sector favored the role of 
DTCPA in terms of patient encouragement to attend the physician, when 
compared with public sector slightly less (72%) than private sector has favored 
DTCPA. However, the overall trend of responses has shown that majority of 
HCP supported direct to consumer pharmaceutical advertisement. Although 
less than one third in private (16%) and almost one third (27%) in public sector 
population did not support DTCPA, while very few (3%) remained neutral to 
express their views on DTCPA. Furthermore, during interviews, it was also 
revealed that physicians themselves were inclined towards digital knowledge 
usage and convinced on the utility of such types of tools, however, majority of 
physicians were not well aware about the term DTCPA. 
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Figure 1. Summary of Physician Perception 
Similarly, on question number 2 (i.e. drug advertisements for patients (can) 
encourage them to voice their previously unspoken concerns with improved 
communication?) the same trend has been observed (Figure 1) that majority 
(84%) of private sector physicians support the stance that DTCPA can help 
patients to speak up with healthcare professional for their unspoken health 
concerns. However, the margin of acceptability was at higher side among 
private sector than public institutes (i.e. 73%). There were also some (15%) 
cases in private sector, which did not favor DTCPA in comparison to public 
sector i.e. 25%. During confirmative interview, it’s further found that the 
content of the advertisement also matter in order to educate the patients rather 
than provoking statements to intervene for their health care decisions. 
Besides this, in response to question number 3 (i.e. drug advertisements for 
patients (can) result in improving diagnoses of currently under-diagnosed 
conditions, by attending physician?) the summary of results (Figure 1) have 
indicated that DTCPA can help early diagnosis of previously undiagnosed 
patients, it may helpful to reduce the rate of mortality and morbidities in 
particular societies. The stance has been supported by largely (84%) physician 
in private sector than public sector i.e. 73%. Although, antithesis exist in few 
(16%) cases of private and some (27%) of them in public sector that DTCPA 
will empower patients. However, majority of HCP has favored DTCPA.  
Subsequently, the summary of question number 4 (i.e. drug advertisements 
for patients (can) result in improving treatment of currently under-treatment 
conditions?) has reflected almost similar trend (Figure 1) as predominantly 
84% of the study population in private sector has backed the importance of 
DTCPA, especially, in the context of Pakistan. Moreover, during interview 
 
Shahzad et al. 
94 Vol. 7, Issue 1 ISSN 2414-2336 (Print), ISSN 2523-2525 (Online) 
 
phase it was evident that private sector has more acceptability for DTCPA as 
compared to public sector (i.e. 75%). 
In response to question number 5 (i.e. drug advertisements for patients (can) 
contribute to increase in self-medications?), the survey results indicate that 
physician are with views that DTCPA can contribute to over commercialism of 
medicines may lead to self-medication and undue consumption of medicines.  
This was a point of indulgence for both the sectors physician, as it was largely 
reflected in private (98%) and public (99%) sector responses. Similar, trend has 
been observed in qualitative phase, which has validated the quantitative phase. 
Finally, the summary of question 6 (i.e. drug advertisements for patients 
(can) contribute to raising health care costs by leading them to request 
interventions?) has indicated that in general (87%) private sector physicians 
have shown concern about DTCPA that it can lead to increase in healthcare 
cost, particularly, when patient will insist for un due interventions such as 
laboratory diagnostics or medicines. However, few (13%) cases among private 
and some (26%) in public sector have shown disagreement with majority of 
study population that DTCPA can increase health care cost of the patients. 
Statistical Significance 
In order to compare the mean values of the public and private sectors physician 
perception about direct to consumer pharmaceuticals advertisements, that 
whether these descriptive are statistically significant or not. Independent 
samples t-test was applied to assess the significance level of the above 
mentioned cross comparison of both the groups. Sample t- test is a popular 
parametric technique that compares the two unrelated variables on same 
continuous dependent variable. Following table 4 provides the group statistics 
of mean perception comparison of the public and private sectors. The mean 
score of private sector i.e. M=3.8932, SD=0.66472 is higher than the public 
sector mean values i.e. M=3.6836, SD=0.80496. 
Table 4. Group Statistics of Public and Private Sectors 





197 3.6836 0.80496 0.05735 
Private 
Sector 
192 3.8932 0.66472 0.04797 
 
Moreover, the Levene test (Table 5) for equality of variance of group has 
been violated (F=29.159, Df =387) and statistically found significant i.e. t = -
2.797***. It means that both the groups have mean difference of perception 
about direct to consumer pharmaceutical advertisement. In this case it seems 
that private sector physicians (M=3.8932, SD=0.66472) are more inclined 
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towards the direct consumer pharmaceutical advertisements as compared to 
public sector (M=3.6836, SD = 0.80496). 
Table 5.   Independent t-test Statistics 
 Equal variances Unequal variances 
Levene’s 
statistics 
F 29.159 0.00 
Sig. 0.000 0.00 
t-test 
T -2.797 -2.804 
Df 387 376.890 
Sig. (2-tailed) 0.005 0.005 




According to Cohen’s 1988 the magnitude of effect size of sample t-test can 
be classified into three categories that is low (d=0.2), medium (d = 0.5) and 
high (d = 0.8) (Lakens, 2013). There are three standard ways to measure the 
effect size, Cohen’s benchmark is an appropriate measure of effect size, 
especially, when two groups have similar standard deviation and sample size. 
Glass Delta’s is an alternate to Cohen’s approach which uses only the standard 
deviation of control group to assess the effect size. Moreover, when groups 
have different sample size the recommended measure is Hedges effect size 
calculator (Lakens, 2013). In current case has taken the output of all three 
measures to benchmark the effect size. Hence, to calculate the effects size 
following formula has been used. Formula: Cohen’s d = (M1 – M2) / SDpooled 
= √ ((SD12 + SD22) / 2. 
The results of calculation revealed more are less same effect size for 
Cohen’s, Glass Delta and Hedge have output of 0.2839, 0.2603 and 0.2835 
respectively. The output range falls under low effect size category for all the 
three categories of measures. It means that public and private sectors have low 
difference of effect size between each other. 
Qualitative Results 
The results revealed that majority of private sector physicians were more likely 
to favor DTCPA in order to encourage patients to attain the HCP for preventive 
or disease treatments. It is further evident that DTCPA can help timely 
diagnosis and self-awareness to managed patients themselves. Moreover, it has 
found that DTCPA can help to improve physician patient discussion, which 
will impact the physician-patient relationship in better way. Besides, through 
follow up interviews, it has also been observed that HCP believe that DTCPA 
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can help to educate patients for better treatment outcome via effective 
counseling or awareness campaigns. HCP in Pakistan are aware from the 
government limitations i.e. financial and educational constraints to provide 
full-fledged health care facilities at national level. In this scenario, DTCPA can 
help to create awareness among communities about different ailments that can 
potentially be transformed into national pandemics if not managed properly 
such as in recent time COVID-19 crises. 
Discussion 
This comparative survey research was set out to fill the research gap identified 
by Zaman et al. (2018) and Shah et al. (2017) about contemporary pharmaceu-
tical marketing practices in the context of local setup of Pakistan. Moreover, 
physician believes and organizational factors impact on physician perception 
about Direct to Consumer Pharmaceutical Advertisement (DTCPA) was set out 
based on Mohammadshahi et al. (2019) research work. 
The results of undertaken study has revealed that majority of physician in 
Pakistan are inclined toward DTCPA. However, private sector physicians are 
comparatively more convinced about DTCPA role for better healthcare 
outcome as compared to private sector. These results have validated the 
findings of Jalal et al. (2018) that fundamental differences of opinion exist 
among physicians, especially, on demographics basis such as public or private 
sectors. Moreover, current findings have endorsed the assumptions of 
Preechavuthinant et al. (2018) that DTCPA can play an important role to 
improve physician patient relationship. According to Siddiqi and Shah (2017a), 
in Pakistan physicians encouraged DTCPA, which is supplementary for health 
care system of Pakistan. DTCPA motivate patients to register themselves 
timely to improve the quality of life, particularly in low socio economic 
countries (Defibaugh, 2019; Epstein & Street, 2011). 
Although, antithesis about DTCPA also exists such as Ortiz and Rosenthal 
(2019) mentioned that increase in DTCPA can lead to mistrust the physician 
decision, patient will more trust the drug advertisements than physicians (Jiang, 
2018). Moreover, Pandey, Jha, and Saha (2019) point out that DTCPA will 
facilitate un-due interventions from patient perspective, and may cause 
dissatisfaction as self-medication trend. In contrast, Defibaugh (2019) 
mentioned that DTCPA will ultimately foster neoliberal patient environment, 
where patients will be better know their miseries of disease and symptoms to 
discuss with healthcare professionals as empowered patient. According to 
Vijayabanu et al. (2018), digitalization and transformation of pharmaceutical 
industry is an auto accelerating phenomena, which can empower the e-patient 
autonomy, however there is high risk associated with such empowerment as 
misleading information (Dahl & Eagle, 2016). Stange (2007) being the 
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strongest opponent of DTCPA has recommended to ban DTCPA due to risks 
associated with human lives.  
However, the solution is to improve the quality of information, the content 
of advertisement should be highly meaningful for consumers rather to mislead 
them (Adams, 2016). Moreover, Siraj and Curley (2018) has endorsed the 
promotion of DTCPA, which is good for patient and health care system 
conditionally to improve the quality of message for both patient and physicians. 
Zaman et al. (2018) also concluded that DTCPA is a positive initiative, this 
will encourage patients for participative role and thereby physicians will need 
to be more prepared to deal with more informed patients. However, it’s 
important to identify the preferred mediums of communication for DTCPA that 
deliver rightly, timely and relevant information for better healthcare outcomes. 
Conclusion and Recommendations 
Private sector physician likelihood towards DTCPA is higher than the public 
sector of Pakistan, which seems little conservative among public institutes. 
However, the overall trend has shown that more than one third study 
population has favored DTCPA in respect to patient empowerment, discussion 
with physician and thereby promotes physician patient relationship.  
However, self-medication and unwanted intervention can be expected, 
which may cause unwanted health related events. Therefore, solution is to 
monitor the content of DTCPA to make it strongly relevant and adhered to 
patient that rightly guide and educate them instead of provoking the patients to 
unnecessarily intervene in their health care decisions. 
Pharmaceutical companies should focus on this enormous potential market 
which is day by day expanding due to increase in information access. 
Moreover, government agencies should also take the leverage of this one click 
huge platform to educate people about basic healthcare importance with public 
private partnership programs. 
Physician patient relationship is complex cognitive interaction for mutual 
goals. It will be scholarly contribution to explore the extent of patient being 
active and involved in health care decisions. Moreover, patient opinion should 
also be assessed on DTCPA whether patients intent to adapt or not? Moreover, 
it’s important to identify the preferred mediums of communication for DTCPA, 
which can deliver rightly, timely and relevant information for better healthcare 
outcomes in local setup of Pakistan. 
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